Sigma Planning Corp lowered its stake in SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report) by 4.3% during the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 12,389 shares of the exchange traded fund’s stock after selling 559 shares during the period. Sigma Planning Corp’s holdings in SPDR S&P Biotech ETF were worth $944,000 at the end of the most recent reporting period.
A number of other hedge funds have also added to or reduced their stakes in XBI. Hollencrest Capital Management bought a new stake in shares of SPDR S&P Biotech ETF during the 4th quarter valued at $25,000. BDO Wealth Advisors LLC boosted its stake in SPDR S&P Biotech ETF by 65.0% during the fourth quarter. BDO Wealth Advisors LLC now owns 330 shares of the exchange traded fund’s stock worth $27,000 after acquiring an additional 130 shares in the last quarter. Northwest Investment Counselors LLC purchased a new stake in SPDR S&P Biotech ETF in the first quarter worth about $27,000. New Hampshire Trust bought a new position in shares of SPDR S&P Biotech ETF during the fourth quarter valued at approximately $29,000. Finally, J Arnold Wealth Management Co purchased a new position in shares of SPDR S&P Biotech ETF during the fourth quarter valued at approximately $29,000.
SPDR S&P Biotech ETF Stock Down 0.1 %
SPDR S&P Biotech ETF stock opened at $79.26 on Thursday. SPDR S&P Biotech ETF has a twelve month low of $72.44 and a twelve month high of $95.18. The company has a market capitalization of $6.08 billion, a P/E ratio of 11.47 and a beta of 0.97. The stock’s 50 day moving average is $84.70 and its 200 day moving average is $83.18.
About SPDR S&P Biotech ETF
SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.
Featured Stories
- Five stocks we like better than SPDR S&P Biotech ETF
- How to Calculate Return on Investment (ROI)
- 3 Best Renewable Energy Stocks as Summer Heat Builds
- Dividend Tax Calculator
- Kinder Morgan Shines With Dividend Yield, Cash Flow, Buybacks
- What is MarketRank™? How to Use it
- 3 Stocks to Buy No Matter Which Way Inflation Moves
Want to see what other hedge funds are holding XBI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report).
Receive News & Ratings for SPDR S&P Biotech ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SPDR S&P Biotech ETF and related companies with MarketBeat.com's FREE daily email newsletter.
